Pierre-David Kramer Email and Phone Number
Pierre-David Kramer work email
- Valid
Pierre-David Kramer personal email
Highly accomplished CFO with extensive life sciences industry experience (Pharma, Medical Devices, Food Supplement), I bring value: ☛ To reach major objectives : - Transformation: M&A, operational integration, carve-out, business model change, set-up new of new international entity- Turnaround: close, sell entities, cut costs, optimize working capital- Digitalisation / ERP set-up☛ Or in urgent situation :- Replacement of a CFO with a scope including IT, legal, supply chain, payroll☛ With a cross-functional perspective, business and operational ☛ With customized solutions :o To the need of international group, Mid-sized companies, PE backed companieso Extended in different industry (Cosmetics, Food Industry, Metal)☛ Agile and mobile geographically in France and in Western Europe (French mother tongue, fluent in English and German)Key words:Turnaround Management, Restructuring, Cost reduction, M&A, Carve-out, Business Development, Strategy, Negotiation, ERP, SAP, Sage X3, Oracle JD Edwards, Business Intelligence tools Leadership, People Development, Change Management, Life Sciences, Healthcare, Pharma ( Rx, OTC, Generics), Medical Device, Food Supplement, Cosmetics, Food Industry, Metal Industry, Executive Interim Management All areas of Finance (budgeting, FP&A, strategic planning, controlling, corporate finance, tax planning, transfer pricing, cash management, IFRS/USGAAP accounting, consolidation, SOX, internal audit), IT, Legal, Purchasing, Industrial Operations, Logistics and Supply Chain Management
Havea
View- Website:
- havea.group
- Employees:
- 938
-
Group Cfo I Management De Transition I Consumer HealthHaveaParis, Fr -
Finance Director - Projects / Interim ManagementEthypharm Nov 2020 - PresentParis -
Interim CfoEurofoil France Feb 2020 - Jul 2020Normandie, FranceUrgent replacement of the CFO during the Covid crisis, within this mid-size industrial company under a reorganization plan, backed by a distressed PE fund -
Interim Finance / Fp&A DirectorOmega Pharma, A Perrigo Company Jun 2019 - Sep 2019Paris -
Chief Financial And Operations OfficerMelisana Pharma 2017 - 2019ParisIn charge of Finance, IT, Industrial Operations, Supply Chain3 entities , Pharma, Medical devices, cosmetics, food supplement Distribution channels: Pharmacies, Hospitals, Mass Market, ExportMain achievement: Simplification of business model & divestment of non-core assets:- Sold medical devices entity , brands , evaluated production site closure.- Restore reliability of financial statements and financial planning after integration of merged entities. -
Chief Financial Officer - CfoEffik 2013 - 2017Brussels Area, Belgium6 european entities and 4 business lines ( Pharmaceutical, OTC, Medical devices, Food supplement)In charge of Finance, Supply Chain, IT, Export - Set up central entrepreneur model, increased capital , introduced new ERP.- Protected key brands , sold licence to export customers- Improved EBITDA and working capital -
Finance DirectorWarner Chilcott 2010 - 2013ParisFrance & Benelux- ex P&G PharmaMain achievement: Carve out of P&G pharma, integration and restructuring: - Recommended and negotiated a deal with Merck - €20m additional sales over 5 years.- Evaluated MBO, restructured company, transferred activities to shared services. - Implemented SAP, rolled-out group transfer price policy, SOX procedures & treasury tools -
Finance DirectorColoplast 2007 - 2010ParisMedical devicesMain achievement: Turnaround of the company following a critical situation post acquisition:- Rebuilt equity after a net loss of €13m in 2006.- Improved Days Sales Outstanding by 9 days generating €5m cash -
Head FinanceNovartis 2005 - 2007Basel, SwitzerlandGlobal Business Unit ( Sales 500 M€)Main achievement: Profitable growth and optimization of the value of the product portfolio:- Improved product profitability through a deal with P&G with a €65m upfront payment.- Evaluated financially M&A of biotech of €400m equity. -
Head Business Planning And AnalysisNovartis 2001 - 2005Basel-SwitzerlandPharmaceutical Production (15 countries, Costs 400 M€)Main achievement: Assessment and implementation of a new manufacturing global strategy:- Improved EBIT by €60m at global level.- Divestment of a plant in Switzerland with net cost savings of €15m.
Pierre-David Kramer Education Details
-
Corporate Finance & Management -
Novartis Finance Excellence Programme -
Food Science And Biotechnology
Frequently Asked Questions about Pierre-David Kramer
What company does Pierre-David Kramer work for?
Pierre-David Kramer works for Havea
What is Pierre-David Kramer's role at the current company?
Pierre-David Kramer's current role is Group CFO I Management de transition i Consumer Health.
What is Pierre-David Kramer's email address?
Pierre-David Kramer's email address is pi****@****adoo.fr
What schools did Pierre-David Kramer attend?
Pierre-David Kramer attended Insead, École Des Ponts Paristech, Harvard Business School, Ensaia - Ecole Nationale Supérieure D'agronomie Et Des Industries Alimentaires.
Who are Pierre-David Kramer's colleagues?
Pierre-David Kramer's colleagues are Thibault Leray, Mohammed Belabid, Lucie Destouches, Sarah B., Antoine Roudier, Vincent Maupas, Eva Roualdès.
Free Chrome Extension
Find emails, phones & company data instantly
Aero Online
Your AI prospecting assistant
Select data to include:
0 records × $0.02 per record
Download 750 million emails and 100 million phone numbers
Access emails and phone numbers of over 750 million business users. Instantly download verified profiles using 20+ filters, including location, job title, company, function, and industry.
Start your free trial